Lucigen Breaking News MDxHealth Q1 Revenues Leap 22 Percent FDA Approves Roche Lung Cancer CDx Assay for Use with AbbVie's Emrelis OraSure Technologies, Targeted Genomics Collaborate for DTC Genetic Celiac Disease Testing Lucid Diagnostics Q1 Revenues Fall 17 Percent Grail Q1 Revenues up 19 Percent Driven by Clinical Test Growth Biodesix Q1 Revenues up 21 Percent as Firm Slashes Full-Year Guidance on Sales Restructuring
